PARP inhibitor AZD2281
| PARP inhibitor AZD2281 | |
|---|---|
| Term | PARP inhibitor AZD2281 |
| Short definition | PARP inhibitor AZD2281 - drug used to treat adults with certain types of prostate cancer, pancreatic cancer, breast cancer or ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. It is also being studied in the treatment of other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
PARP inhibitor AZD2281 - drug used to treat adults with certain types of prostate cancer, pancreatic cancer, breast cancer or ovarian cancer, fallopian tube cancer, or primary peritoneal cancer. It is also being studied in the treatment of other types of cancer. The PARP inhibitor AZD2281 blocks an enzyme involved in many cell functions, including repairing DNA damage. Blocking this enzyme can help prevent cancer cells from repairing their damaged DNA, causing them to die. The PARP inhibitor AZD2281 is a type of PARP inhibitor. Also called AZD2281, Lynparza and Olaparib
External links
- Medical encyclopedia article on PARP inhibitor AZD2281
- Wikipedia's article - PARP inhibitor AZD2281
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski